Thus, more studies are needed to establish the therapeutic efficacy of, for example, combined tryptophan, kynurenine, and indole metabolism modulation on CKD progression (potentially via reduction in IDO activity with concurrent supplementation with IPA). Here, IDO1 is linked to chronic kidney disease.